Complete financial results for the third quarter and outlook for the fourth quarter of 2025 can be found in the shareholder ...

Cystic fibrosis (CF) therapeutics refer to treatments designed to manage and alleviate the symptoms of cystic fibrosis, a ...

By Trevor Hunnicutt, Laurie Chen and Mei Mei Chu BUSAN, South Korea/BEIJING (Reuters) -U.S. President Donald Trump hailed a ...

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference ...

The new thing is to sue the people who have publicists and public relations people who are going to want to put the lawsuit ...

KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid ...